1. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study
- Author
-
Zujiang Yu, Guo-Qiang Zhang, Guang-Lin Cui, Guo-Fan Zhang, Qing-Lei Zeng, Jiang-Hai Xu, Guo-Tao Li, Guang-Ming Li, Fanpu Ji, Fu-Sheng Wang, and Wan-Bao Lin
- Subjects
Adult ,Male ,medicine.medical_specialty ,Bilirubin ,Dynamic changes ,Aalanine aminotransferase ,Infectious and parasitic diseases ,RC109-216 ,Liver injury ,Chronic liver disease ,Aspartate aminotransferase ,Severity of Illness Index ,Gastroenterology ,digestive system ,Liver function ,chemistry.chemical_compound ,Liver Function Tests ,Internal medicine ,Humans ,Severe acute respiratory syndrome coronavirus 2 ,Medicine ,Aspartate Aminotransferases ,Viral shedding ,Aged ,Retrospective Studies ,medicine.diagnostic_test ,biology ,Coronavirus disease 2019 ,SARS-CoV-2 ,business.industry ,COVID-19 ,Alanine Transaminase ,Middle Aged ,medicine.disease ,Infectious Diseases ,Liver ,Alanine transaminase ,chemistry ,biology.protein ,Female ,business ,Liver function tests ,Biomarkers ,TBIL ,Research Article - Abstract
Background Liver injuries have been reported in patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate the clinical role played by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods In this multicentre, retrospective study, the parameters of liver function tests in COVID-19 inpatients were compared between various time-points in reference to SARS-CoV-2 shedding, and 3 to 7 days before the first detection of viral shedding was regarded as the reference baseline. Results In total, 70 COVID-19 inpatients were enrolled. Twenty-two (31.4%) patients had a self-medication history after illness. At baseline, 10 (14.3%), 7 (10%), 9 (12.9%), 2 (2.9%), 15 (21.4%), and 4 (5.7%) patients already had abnormal alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), albumin, and total bilirubin (TBIL) values, respectively. ALT and AST abnormal rates and levels did not show any significant dynamic changes during the full period of viral shedding (all p > 0.05). The GGT abnormal rate (p = 0.008) and level (p = 0.033) significantly increased on day 10 of viral shedding. Meanwhile, no simultaneous significant increases in abnormal ALP rates and levels were observed. TBIL abnormal rates and levels significantly increased on days 1 and 5 of viral shedding (all p p Conclusions SARS-CoV-2 does not directly lead to elevations in ALT and AST but may result in elevations in GGT and TBIL; albumin decreased extraordinarily even when SARS-CoV-2 shedding ended.
- Published
- 2021